Menu

GSK headquarters

GSK recently became the 10th drug manufacturer to expand its 340B claims data requirements to in-house pharmacy dispensing.

Two More Drugmakers Announce 340B In-House Pharmacy Data Requirements

June 9, 2026 William Newton, Editor-in-Chief 340B Report Views

London-based pharmaceutical giant GSK and Sweden-based rare disease drugmaker Sobi recently announced they will begin requiring 340B covered entities to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton

Federal Judge Tosses AbbVie Challenge to Mississippi’s 340B Contract Pharmacy Law

Trump Picks Johns Hopkins Professor Who’s Scrutinized 340B Program for HHS Assistant Secretary